AI, Data and Partnerships: The Building Blocks for More Sustainable Clinical Trials

Sas Maheswaran discusses how artificial intelligence, data and strategic partnerships can make clinical trials more sustainable – both financially and environmentally.

Guide

A Comprehensive Guide to Adaptive Site Monitoring

Blog

RBQM for the Mid Market Explained

Mid-market sponsors are expected to meet the same ICH E6(R3) standards as large pharma, often with...

Blog

5 Myths Mid-Market Teams Believe About RBQM and What ICH E6(R3) Actually Requires

Risk-Based Quality Management (RBQM) is no longer a future-state concept. Under ICH E6(R3), it is a...

Blog

Modern RBQM Has Evolved. Is Your Organization Ready?

Most sponsors and CROs are now fluent in the language of Risk-Based Quality Management (RBQM). Terms...